 |
Journal articles
How to assess the role of Pt and Zn in the nephrotoxicity of Pt anti-cancer drugs?: An investigation combining mXRF and statistical analysis. Part II: Clinical application
Abstract : In this contribution, an approach developed previously for mice is used for human biopsy. In the case of patient 1, Pt detection is performed 6 days after the last oxaliplatin infusion, while for patient 2, the biopsy was performed more than 15 days after his first platin infusion and several dialysis. Even for these biological samples, experiments show that synchrotron mediated mXRF is a suitable tool to detect Pt in kidney biopsy, and thus probably for any organ exposed to Pt. Therefore, mXRF could also be of major interest to decipher the mechanism beyond Pt induced neurotoxicity, ototoxicity on human biopsy. Pharmacoavailability of chemotherapies is a major concern because some treatment failures are explained by poor tumor penetration of the active molecule. mXRF could be an elegant way to map the distribution of Pt inside cancerous cells at the micrometer scale. Pt and Zn are only two of the numerous trace elements that mXRF can detect; heavy metal intoxication diagnosis and the toxicity mechanism probably could also benefit from this innovative technique.
Cited literature [6 references]
https://hal.sorbonne-universite.fr/hal-01297887
Contributor : Gestionnaire Hal-Upmc <>
Submitted on : Tuesday, April 5, 2016 - 10:06:30 AM
Last modification on : Wednesday, December 4, 2019 - 4:38:55 PM
Document(s) archivé(s) le : Monday, November 14, 2016 - 3:56:48 PM
Contributor : Gestionnaire Hal-Upmc <>
Submitted on : Tuesday, April 5, 2016 - 10:06:30 AM
Last modification on : Wednesday, December 4, 2019 - 4:38:55 PM
Document(s) archivé(s) le : Monday, November 14, 2016 - 3:56:48 PM
File
how.pdf
Publication funded by an institution
Licence
Distributed under a Creative Commons Attribution 4.0 International License
